Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Total Debt (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Total Debt for 16 consecutive years, with $3.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Total Debt fell 73.16% to $3.2 million in Q4 2025 year-over-year; TTM through Nov 2025 was $3.2 million, a 73.16% decrease, with the full-year FY2025 number at $3.2 million, down 73.16% from a year prior.
  • Total Debt was $3.2 million for Q4 2025 at Cryo Cell International, down from $11.4 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $12.6 million in Q2 2024 to a low of $875000.0 in Q1 2021.
  • A 5-year average of $5.7 million and a median of $3.6 million in 2023 define the central range for Total Debt.
  • Peak YoY movement for Total Debt: crashed 82.86% in 2021, then skyrocketed 1079.48% in 2023.
  • Cryo Cell International's Total Debt stood at $875000.0 in 2021, then surged by 259.74% to $3.1 million in 2022, then tumbled by 33.36% to $2.1 million in 2023, then surged by 463.95% to $11.8 million in 2024, then tumbled by 73.16% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Total Debt are $3.2 million (Q4 2025), $11.4 million (Q3 2025), and $7.5 million (Q2 2025).